Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorBeijing Institute of Heart, Lung and Blood Vessel Diseases

About this trial

The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.

Eligibility criteria

Qualifiers

All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.

Patients with initial suspicion of having AAD were perspectively enrolled.

Disqualifiers

Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;

Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;

Patients who entered the hospital for checkups after surgery.

Patients in whom there is little or no suspicion of a life-threatening disease;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,500 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Lead sponsor

Beijing Luhe Hospital

Collaborator

The First Affiliated Hospital of Dalian Medical University

Collaborator

The First Hospital of Jilin University

Collaborator

First Affiliated Hospital, Sun Yat-Sen University

Collaborator

The General Hospital of Northern Theater Command

Collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborator